163 results on '"Harris, David C.H."'
Search Results
2. Participant Perceptions in a Long-term Clinical Trial of Autosomal Dominant Polycystic Kidney Disease
3. Innate lymphoid cells in kidney diseases
4. Up-Regulation of DNA Damage Response Signaling in Autosomal Dominant Polycystic Kidney Disease
5. Ethics of kidney care in the era of COVID-19
6. Strategic plan for integrated care of patients with kidney failure
7. α3 Integrin of Cell-Cell Contact Mediates Kidney Fibrosis by Integrin-Linked Kinase in Proximal Tubular E-Cadherin Deficient Mice
8. Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury
9. Interleukin-33 Exacerbates IgA Glomerulonephritis in Transgenic Mice Overexpressing B Cell Activating Factor
10. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in the Middle East
11. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in South Asia
12. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Newly Independent States and Russia
13. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Eastern and Central Europe
14. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Africa
15. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in North America and the Caribbean
16. Understanding distribution and variability in care organization and services for the management of kidney care across world regions
17. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Oceania and South East Asia
18. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Western Europe
19. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Latin America
20. Global variation in kidney care: national and regional differences in the care and management of patients with kidney failure
21. International Society of Nephrology Global Kidney Health Atlas: structures, organization and services for the management of kidney failure in North and East Asia
22. International consensus definitions of clinical trial outcomes for kidney failure: 2020
23. Corrigendum to “Tonelli M, Nkunu V, Varghese C, et al. Framework for establishing integrated kidney care programs in low- and middle-income countries” Kidney Int Suppl. 2020;10:e19–e23
24. Providing care for patients with kidney failure over the next decade
25. Strategic plan for integrated care of patients with kidney failure
26. International collaborative efforts to establish kidney health surveillance systems
27. International consensus definitions of clinical trial outcomes for kidney failure: 2020
28. Macrophages in Renal Disease
29. Framework for establishing integrated kidney care programs in low- and middle-income countries
30. Dialysis funding, eligibility, procurement, and protocols in low- and middle-income settings: results from the International Society of Nephrology collection survey
31. The second Global Kidney Health Summit outputs: developing a strategic plan to increase access to integrated end-stage kidney disease care worldwide
32. Global case studies for chronic kidney disease/end-stage kidney disease care
33. Capturing and monitoring global differences in untreated and treated end-stage kidney disease, kidney replacement therapy modality, and outcomes
34. Regulatory innate lymphoid cells suppress innate immunity and reduce renal ischemia/reperfusion injury
35. The CD40–CD154 co-stimulation pathway mediates innate immune injury in adriamycin nephrosis
36. Can murine diabetic nephropathy be separated from superimposed acute renal failure?
37. DNA vaccination with naked DNA encoding MCP-1 and RANTES protects against renal injury in adriamycin nephropathy
38. Proximal tubule cells stimulated by lipopolysaccharideinhibit macrophage activation
39. Proximal tubule cells stimulated by lipopolysaccharide inhibit macrophage activation
40. Plasmin in renal interstitial fibrosis: Innocent or guilty?
41. Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease
42. A blast from the mast?
43. Transfection of tubule cells with Fas ligand causes leukocyte apoptosis
44. Depletion of CD4+ T cells aggravates glomerular and interstitial injury in murine adriamycin nephropathy
45. Role of CD8+ cells in the progression of murine adriamycin nephropathy
46. Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events
47. Lipopolysaccharide-induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-κB dependent
48. Inhibition of nuclear factor-κB activation reduces cortical tubulointerstitial injury in proteinuric rats
49. Renal pathology practice globally: identifying needs and meeting the challenge
50. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.